Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), given each month during the transmission season, is recommended for children living in areas of the Sahel where malaria transmission is highly seasonal. The recommendation for SMC is currently limited to children under five years of age, but, in many areas of seasonal transmission, the burden in older children may justify extending this age limit. This study was done to determine the effectiveness of SMC in Senegalese children up to ten years of age. METHODS AND FINDINGS: SMC was introduced into three districts over three years in central Senegal using a stepped-wedge cluster-randomised design. A census of the population was undertaken and a surveillance system was established to record all deaths and to record all cases of malaria seen at health facilities. A pharmacovigilance system was put in place to detect adverse drug reactions. Fifty-four health posts were randomised. Nine started implementation of SMC in 2008, 18 in 2009, and a further 18 in 2010, with 9 remaining as controls. In the first year of implementation, SMC was delivered to children aged 3-59 months; the age range was then extended for the latter two years of the study to include children up to 10 years of age. Cluster sample surveys at the end of each transmission season were done to measure coverage of SMC and the prevalence of parasitaemia and anaemia, to monitor molecular markers of drug resistance, and to measure insecticide-treated net (ITN) use. Entomological monitoring and assessment of costs of delivery in each health post and of community attitudes to SMC were also undertaken. About 780,000 treatments were administered over three years. Coverage exceeded 80% each month. Mortality, the primary endpoint, was similar in SMC and control areas (4.6 and 4.5 per 1000 respectively in children under 5 years and 1.3 and 1.2 per 1000 in children 5-9 years of age; the overall mortality rate ratio [SMC: no SMC] was 0.90, 95% CI 0.68-1.2, p = 0.496). A reduction of 60% (95% CI 54%-64%, p < 0.001) in the incidence of malaria cases confirmed by a rapid diagnostic test (RDT) and a reduction of 69% (95% CI 65%-72%, p < 0.001) in the number of treatments for malaria (confirmed and unconfirmed) was observed in children. In areas where SMC was implemented, incidence of confirmed malaria in adults and in children too old to receive SMC was reduced by 26% (95% CI 18%-33%, p < 0.001) and the total number of treatments for malaria (confirmed and unconfirmed) in these older age groups was reduced by 29% (95% CI 21%-35%, p < 0.001). One hundred and twenty-three children were admitted to hospital with a diagnosis of severe malaria, with 64 in control areas and 59 in SMC areas, showing a reduction in the incidence rate of severe disease of 45% (95% CI 5%-68%, p = 0.031). Estimates of the reduction in the prevalence of parasitaemia at the end of the transmission season in SMC areas were 68% (95% CI 35%-85%) p = 0.002 in 2008, 84% (95% CI 58%-94%, p < 0.001) in 2009, and 30% (95% CI -130%-79%, p = 0.56) in 2010. SMC was well tolerated with no serious adverse reactions attributable to SMC drugs. Vomiting was the most commonly reported mild adverse event but was reported in less than 1% of treatments. The average cost of delivery was US$0.50 per child per month, but varied widely depending on the size of the health post. Limitations included the low rate of mortality, which limited our ability to detect an effect on this endpoint. CONCLUSIONS: SMC substantially reduced the incidence of outpatient cases of malaria and of severe malaria in children, but no difference in all-cause mortality was observed. Introduction of SMC was associated with an overall reduction in malaria incidence in untreated age groups. In many areas of Africa with seasonal malaria, there is a substantial burden in older children that could be prevented by SMC. SMC in older children is well tolerated and effective and can contribute to reducing malaria transmission. TRIAL REGISTRATION: ClinicalTrials.gov NCT00712374.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Health facilities, strategically chosen as clusters in numerous studies, underscore the emphasis on healthcare delivery and interventions within controlled environments.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The everyday use of hospitals and clinics as clusters is rooted in their pivotal role in healthcare delivery, enabling the implementation and evaluation of interventions to enhance patient outcomes (26, 27, 30–34, 36–47, 49, 50, 52–71, 73–75, 77–81, 83–89, 91–96, 98–102, 104, 105, 107, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies that integrated health facility-based interventions with community outreach often used mixed-setting clusters (33–36, 38, 48, 54, 61, 67, 72, 76, 78, 80, 92, 99, 103, 106–108).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“Many of the interventions involved distributing and administering pharmaceutical treatments to prevent or manage diseases (28, 34, 36, 38–40, 42, 61, 90, 91, 93, 96, 98).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“Studies such as those by Calum Davey (35) and Badara Cisse (34) illustrate the value of accounting for temporal trends to reduce bias, aligning with guidance on SWD's analytical strengths (117).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The stepped wedge trial design: a systematic review
Brown, C. A., & Lilford, R. J. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-54 · Cited by 907
Cissé, B., Sokhna, C., Boulanger, D., Milet, J., Bâ, E. H., Richardson, K., Hallett, R., Sutherland, C., Simondon, K., Simondon, F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68264-0 · Cited by 209 · cited 1×
“Stepped-Wedge Design SMC (then known as intermittent preventive treatment in children [IPTc]) had been shown prior to the planning of this study to be highly effective in clinical trials [10,11], but it was questioned whether the intervention could be delivered on a large scale at reasonable cost, whether it would be…”
MethodCairns, M., Roca-Feltrer, A., Garske, T., Wilson, A. L., Diallo, D., Milligan, P. J., Ghani, A. C., & Greenwood, B. M. (2012) · Nature Communications · doi:10.1038/ncomms1879 · Cited by 186 · cited 1×
“1 cases per child per year, areas where SMC is likely to be most cost effective [2,3].”
BackgroundOkiro, E. A., Al-Taiar, A., Reyburn, H., Idro, R., Berkley, J. A., & Snow, R. W. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-4 · Cited by 153 · cited 1×
“In some parts of the areas suitable for SMC, the proportional burden of malaria in older children is increasing [7], reflecting slower acquisition of natural immunity; in these areas, Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten”
BackgroundHemming, K., & Girling, A. (2014) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1401400208 · Cited by 127
Sokhna, C., Cissé, B., Bâ, E. H., Milligan, P., Hallett, R., Sutherland, C., Gaye, O., Boulanger, D., Simondon, K., Simondon, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001471 · Cited by 99
NDiaye, J. L., Cissé, B., Ba, E. H., Gomis, J. F., Ndour, C. T., Molez, J. F., Fall, F. B., Sokhna, C., Faye, B., Kouevijdin, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162563 · Cited by 60
Self-citationNew Malaria-Control Policies and Child Mortality in Senegal: Reaching Millennium Development Goal 4
Trape, J.-F., Sauvage, C., Ndiaye, O., Douillot, L., Marra, A., Diallo, A., Cisse, B., Greenwood, B., Milligan, P., Sokhna, C., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir805 · Cited by 36
Noor, A. M., Kibuchi, E., Mitto, B., Coulibaly, D. M., Doumbo, O. K., & Snow, R. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136919 · Cited by 36
Lô, A. C., Faye, B. T., Bâ, E. H., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-137 · Cited by 27 · cited 3×
“falciparum infection at the end of the transmission season were more likely to carry the pfmdr1 86Y mutation associated with AQ resistance if they came from areas where SMC had been implemented [14], but the effect of this on the spread of resistance may be mitigated to some extent by the much lower prevalence of infe…”
BackgroundInfluential
Cited by
Items 101–190 of 190
Ko, Y. K., Kagaya, W., Chan, C. W., Kanamori, M., Mbugua, S. M., Rotich, A. K., Kanoi, B. N., Ngara, M., Gitaka, J., & Kaneko, A. (2024) · BMJ Public Health · doi:10.1136/bmjph-2024-001557 · Cited by 8
Rotimi, K., Aiden, J., Dabes, C., Maduka, K., Oguche, D., Itiola, A. J., & Oresanya, O. B. (2022) · Scientific African · doi:10.1016/j.sciaf.2022.e01283 · Cited by 6
Systematic review on the cost of seasonal malaria chemoprevention (SMC)
Ruisch, A., Iodice, M., Mathur, I., Harris, S., Walker, D. G., Owusu, R., Nonvignon, J., & Gilmartin, C. (2024) · Malaria Journal · doi:10.1186/s12936-024-05217-1 · Cited by 5
“Three studies [17–19] lacked reporting on ‘Characterizing distributional effects’ (#19) compared to two studies [15, 16] who included it.”
Nice, J., Hiruy, H. N., Eckert, E. L., Eisele, T. P., & Ashton, R. A. (2020) · Journal of Global Health · doi:10.7189/jogh.10.020413 · Cited by 5
Somé, A. F., Conrad, M. D., Kabré, Z., Fofana, A., Yerbanga, R. S., Bazié, T., Neya, C., Somé, M., Kagambega, T. J., Legac, J., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01534-23 · Cited by 6
Buchwald, A. G., Vareta, J. A., Nwagbata, O., McCann, R. S., Sixpence, A., Matengeni, A., Kamzati, M., Mangani, C., Seydel, K. B., Wilson, M. L., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01407-x · Cited by 5
“Largecluster-randomizedtrialshavefoundthat,evenwith imperfect coverage, targeting parasite-clearing treatment to all school-age children leads to decreased community-level malaria prevalence 29,30 .”
Lado, P., Gray, L. I., Sougue, E., Knight, A. L., Sorensen, M. R., Leon, A.-S., Ring, M. E., Pugh, G., Randall, J. E., Coffin, K. L., et al. (2026) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.25-0745 · Cited by 4
Seasonal Malaria Chemoprevention: An Evolving Research Paradigm
Snow, R. W. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002176 · Cited by 5
Targeting Malaria Hotspots to Reduce Transmission Incidence in Senegal
Sallah, K., Giorgi, R., Bâ, E. H., Piarroux, M., Piarroux, R., Griffiths, K., Cissé, B., & Gaudart, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010076 · Cited by 10
“Public Health 2021, 18, x 3 of 20 1 Sciences Economiques et Sociales de la Santé et Traitement de de l’Information Médicale (SESSTIM), Institut de Recherche pour le Développement (IRD), Institut National de la Santé et de la Recherche médicale (INSERM), Aix Marseille Université, 13005 Marseille, France; kankoe.sallah@…”
MethodManga, I. A., Tairou, F., Seck, A. M., Kouevidjin, E., Sylla, K., Sow, D., Gueye, A. B., Bâ, M., Ndiaye, M., Tine, R. C. K., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.18057.1 · Cited by 7
Burgert, L., Reiker, T., Golumbeanu, M., Möhrle, J. J., & Penny, M. A. (2021) · medRxiv · doi:10.1101/2021.07.05.21250483 · Cited by 4
Lemant, J., Champagne, C., Houndjo, W., et al. (2024) · medRxiv · doi:10.1101/2024.04.25.24306333 · Cited by 4
Ly, A. Y., Allaya, M. M., Loum, M. A., Gning, L. D., Sy, O., Bakhoum, L. N., Ndiaye, K., Ndiop, M., Sall, F. B., Ndiaye, J. L., et al. (2025) · BMC Artificial Intelligence · doi:10.1186/s44398-025-00007-4 · Cited by 3
“This pattern may indicated potential benefits of SMC where implemented effectively [47–49] though again, causality cannot be inferred.”
Diarra, N. H. (2021) · Mali Santé Publique · doi:10.53318/msp.v11i1.1899 · Cited by 7
Ndiaye, A., Morlighem, C., Diène, A. N., Kane, M., Diallo, A., Tairou, F., Nourdine, M. A., Sarr, P. C., Konaté, L., Faye, O., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05388-5 · Cited by 4
“…of integrated malaria control interventions over the last few years, including the seasonal malaria chemoprevention and indoor residual spraying, which resulted in the global decline of malaria in the whole region, but the persisting in few hotspots, where residual transmission still ongoing [5].”
Afolabi, M. O., Sow, D., Agbla, S. C., Fall, E. H. B., Sall, F. B., Seck, A. M., Manga, I. A., Mbaye, I., Loum, M. A., Camara, B., et al. (2023) · Malaria Journal · doi:10.1186/s12936-023-04784-z · Cited by 3
“These factors have been documented to be effective strategies in the vertical implementation of MDA and SMC in most African settings [25, 27, 28].”
BackgroundLemant, J., Champagne, C., Houndjo, W., Aïssan, J., Aïkpon, R. Y., Houetohossou, C., Kpanou, S., Goers, R., Affoukou, C. D., & Pothin, E. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004509 · Cited by 6
“However similar odds ratios of mortality and incidence during transmission seasons [8] seem to indicate efficacy is similar in both age groups.”
Manga, I. A., Bâ, M., Tairou, F., Seck, A. M., Kouevidjin, E., Sow, D., Sylla, K., Ndiaye, M., Fall, F. B., Gueye, A. B., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17888.1 · Cited by 3
Munsey, A., Digre, P., Hicks, J. T., Wagman, J., Robertson, M., Alao, M., Hounto, A. O., Gansané, A., Débé, S., Candrinho, B. N., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-018572 · Cited by 2
“The opportunity to survey ANC attendees regarding ITN ownership may extend the utility of data which could be collected from this easily accessible population, whereas responses related to treatment-seeking are prone to bias.”
Huang, S., Baker, K. S., Ibinaiye, T., Oresanya, O. B., Nnaji, C., & Richardson, S. (2024) · Tropical Medicine & International Health · doi:10.1111/tmi.14019 · Cited by 3
Güler, J. L., & Rosenthal, P. J. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy871 · Cited by 2
Kazanga, B., Cissoko, M., Katile, A., Boudoua, E., Legendre, E., Kamaté, B., Kanoute, M., Kone, P., Djiguiba, A., Poudiougo, O. A., et al. (2025) · medRxiv · doi:10.1101/2025.11.26.25341058 · Cited by 1
“Those with eMOI ≤ 1.1 were classified as monoclonal (single parasite genotype), which is a practical threshold supported by several studies[13,23].”
InfluentialMoreno, M., Barry, A., Gmeiner, M., Yaro, J. B., Sermé, S. S., Byrne, I., Ramjith, J., Ouédraogo, A., Soulama, I., Grignard, L., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081682 · Cited by 1
“The T max for AQ is around 2 days (IQR 1–3 days) and drug concentrations wane rapidly between days 3 and 7.”
BackgroundBakaï, T. A., Gense, M., Vanhems, P., Iwaz, J., Thomas, A., Atcha-Oubou, T., Tchadjobo, T., Voirin, N., & Khanafer, N. L. (2024) · Malaria Journal · doi:10.1186/s12936-024-04988-x · Cited by 2
Affoukou, C. D., Aïkpon, R. Y., Damiens, G., Boni, O. R. B., Padonou, G., Houndjo, W., Houetohossou, C., Sohizoun, E., Lègba, T., Ogouyemi, A., et al. (2024) · Open Journal of Epidemiology · doi:10.4236/ojepi.2024.144041 · Cited by 1
Wazodan, A. M., Moustapha, L. M., Doutchi, M., et al. (2024) · Pan African Medical Journal · doi:10.11604/pamj.2024.49.66.45130 · Cited by 1
“Des études au Sénégal, au Mali et au Niger avait rapporté des résultats similaires [4,14-18].”
Djedanem, M., Salé, N. M., Aminou, E. Y. Y. M., Testa, J., & Jambou, R. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005124 · Cited by 1
Ikechukwu, E. C., Okereke, E., Ogunmola, O., Chukwumerije, J., Emeto, D. C., Salifu, E., Balogun, A., Oguoma, C., Shekarau, E., Ogbulafor, N. C., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05604-2 · Cited by 3
“15 While previous evidence from both randomised and observational studies in different countries across sub-Saharan Africa has shown that SMC is highly effective 11,14,16,17,18,19,20,21 , much of the current evidence on SMC effectiveness is based on studies conducted several years ago.”
Djedanem, M., Yacoubou, M. A. Y., Zakari, A., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-12286-3 · Cited by 1
“Currently, children over the age of five are not included in the SMC target group because children under the age of five account for approximately 76% of malaria deaths in Africa [13].”
Morlighem, C., Visée, C., Nnanatu, C. C., Tine, M. W., (24176702), A. N. D., & Linard, C. (2026) · BMJ Global Health · doi:10.1136/bmjgh-2025-023003 · Cited by 2
RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of Plasmodium falciparum
von Seidlein, L., Hanboonkunupakarn, B., Jittmala, P., & Pukrittayakamee, S. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170101 · Cited by 1
Nadakou, N. T., Paraïso, M. N., Tapha, O., lamine, M. M., Yobo, J. B., Alkassoum, S. I., Fidèl, T., Lazoumar, H. R., & Adehossi, E. O. (2024) · Advances in Infectious Diseases · doi:10.4236/aid.2024.141007 · Cited by 1
Lee, K. M., Yang, G. M., & Cheung, Y. B. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02379-z · Cited by 1
“In the example of a seasonal malaria chemoprevention trial that was terminated early due to interim analysis results [23], unexposed clusters were clusters that were randomized to implement the interventions at later time periods.”
BackgroundInfluentialKambou, S. A. E., Sondo, P., Kaboré, B., Bayala, I. M. C., Kouevi, A. F. C., Compaore, E. W., Millogo, K. S., Bouda, I., Rouamba, T., Kazienga, A., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05453-z · Cited by 2
“For example, Cissé et al . observed a reduction in transmission when extending SMC in children up to ten years [45].”
Musa, Z. A., Akinsolu, F. T., Salako, A. O., Abodunrin, O. R., Ola, O. M., & Ezechi, O. C. (2026) · Frontiers in Epidemiology · doi:10.3389/fepid.2026.1529289
Resurrected malaria strategy saves thousands of lives in Africa
Maxmen, A. (2017) · Nature · doi:10.1038/nature.2017.22982
The unanticipated benefits of protecting young children from malaria
Cohee, L. M., & Laufer, M. K. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30285-3
Sokhna, C., & Cissé, B. (2018) · IRD Éditions eBooks · doi:10.4000/books.irdeditions.31572
Bikundi, E. M., Robert, A. R., Bouland, C., Akotionga, E., Sougou, N. M., & Coppieters, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-523510/v1
Sougou, N. M., Faye, A., Lèye, M. M. M., Bassoum, O., & Seck, I. (2021) · Research Square · doi:10.21203/rs.3.rs-732206/v1
Tairou, F., Diallo, A., Sy, O., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-810164/v1
Oumar, A. A., Yacouba, S., Sanogo, M., et al. (2021) · HEALTH SCIENCES AND DISEASE · doi:10.5281/hsd.v22i10.3022
Rotimi, K., Aiden, J., Dabes, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1327256/v1
“Seasonal Malaria Chemoprevention targeted at children under ve years is one of such preventive interventions [3].”
BackgroundAfolabi, M. O., Sow, D., Ndiaye, J. L., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1690342/v1
Sy, O., Sarr, P. C., Assogba, B. S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2090428/v1
Bikundi, E. M., Robert, A. R., Bouland, C., Akotionga, E., Sougou, N. M., & Coppieters, Y. (2022) · The Open Infectious Diseases Journal · doi:10.2174/18742793-v14-e221227-2022-2
Azeez, M. M., & Akinbo, F. O. (2019) · SCIREA Journal of Clinical Medicine · doi:10.54647/cm321077
Ko, Y. K., Kagaya, W., Chan, C. W., Kanamori, M., Mbugua, S. M., Rotich, A. K., Kanoi, B. N., Ngara, M., Gitaka, J., & Kaneko, A. (2024) · medRxiv · doi:10.1101/2024.05.08.24307059
Salangwa, C., Munthali, R., Mfune, L., et al. (2024) · Academia Medicine · doi:10.20935/acadmed6237
Gao, C., Huang, S., Ibinaiye, T., et al. (2024) · Tropical Medicine and Health · doi:10.1186/s41182-024-00642-z
Population impact of malaria control interventions in the health district of Kati, Mali
Katilé, A., Sagara, I., Cissoko, M., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0289451
Manga, I. A., Mhadji, A., Lam, A., Diouf, M. P., Minlekib, C. P., Tairou, F., Seck, A. M., Faye, B., Ndiaye, M., & Ndiaye, J. L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318037 · Cited by 1
“Several operational research studies on SMC have shown the strategy to be cost-effective [3,4] and well-tolerated [5,6].”
Sonounameto, R. C., Damien, G. B., Sambo, T. A., Houndjo, W., Aïssan, J., Aïkpon, R. Y., Dandonougbo, C., Kakaï, R. G., & Pothin, E. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-004335 · Cited by 1
Advances in population-based interventions to control falciparum malaria
Glossop, S. E., Peto, T. J., & Adhikari, B. (2025) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traf088 · Cited by 1
“24 A subsequent study that reported outcomes by age group showed SMC had a similar effect in children ages 5–9 y 25 and also led to a 26% reduction in older, untreated groups.”
Monzó, H. B., Gomez, S. R., Sow, D., Lô, A. C., Diouf, M. P., Seck, A. M., Mbaye, I., Fall, E. B., Patterson, C., Soremekun, S., et al. (2025) · Current Research in Parasitology and Vector-Borne Diseases · doi:10.1016/j.crpvbd.2025.100320
“Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine was introduced in 2013 in Saraya and in 2019 in Diourbel, achieving high coverage in both districts (Ciss ´ e et al., 2016; MSASS, 2022).”
Owusu, R., Gilmartin, C., Diawara, H., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-018042
“14 A recent systematic review found that out of the six costing studies on SMC, 12 15–18 only one study examined the full opportunity cost of SMC implementation from a societal perspective.”
InfluentialRosenthal, P. J. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf616
Rotich, B., Kimachas, E., Kipkoech, J., Kirwa, E., Markwalter, C. F., Ekai, D., Mwangi, A., Hulle, S. V., Menya, D., & O’Meara, W. P. (2025) · medRxiv · doi:10.64898/2025.11.30.25341333
Bakaï, T. A., Thomas, A., Iwaz, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603189
Moukenet, A., de Cola, M. A., Ward, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17065914
Bakaï, T. A., Thomas, A., Iwaz, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603177
Bakaï, T. A., Thomas, A., Iwaz, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603180
Moukenet, A., de Cola, M. A., Ward, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17065920
Bakaï, T. A., Thomas, A., Iwaz, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603186
Moukenet, A., de Cola, M. A., Ward, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17065917
Additional file 1 of Spatio-temporal variation of malaria hotspots in Central Senegal, 2008–2012
Dieng, S., Ba, E. H., Cissé, B., Sallah, K., Guindo, A., Ouedraogo, B., Piarroux, M., Rebaudet, S., Piarroux, R., Landier, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12502649
Kirakoya-Samadoulougou, F., Brouwere, V. D., Fokam, A. F., Ouédraogo, M., & Yé, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19728035
Bakaï, T. A., Thomas, A., Iwaz, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603183
Bakaï, T. A., Thomas, A., Iwaz, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603174
Additional file 2 of Spatio-temporal variation of malaria hotspots in Central Senegal, 2008–2012
Dieng, S., Ba, E. H., Cissé, B., Sallah, K., Guindo, A., Ouedraogo, B., Piarroux, M., Rebaudet, S., Piarroux, R., Landier, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12502655
Lam, A., Lô, A. C., Catriona, P., Sylla, K., Khadime, K., Aida, G., Manga, I. A., Lélo, S., Fall, C. B., Pierre, D., et al. (2025) · International Journal of Infectious Diseases and Therapy · doi:10.11648/j.ijidt.20251004.14
Menya, D., Kimachas, E., Rotich, B., et al. (2026) · medRxiv · doi:10.64898/2026.02.10.26346051
Malaria Incidence Dynamics in the Context of Expanded Seasonal Chemoprevention in Mali, 2016–2018
Rochat, I. C., & Favre, M. L. (2025) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/wk8jarwhwu
Otoo, B. A. F., Opoku, M. M., Seaneke, S. K., Darko, D. M., Sabblah, G. T., & Bonful, H. A. (2026) · Malaria Journal · doi:10.1186/s12936-026-05851-x · Cited by 1
“Nevertheless, most reported ADRs remain mild and self-limiting [32–36], with vomiting consistently identified as a common reaction to SPAQ.”
Okek, E. J., Jehopio, J., Sande, O. J., Musinguzi, B., Awor, S., Asio, J., Le, D. K., (4427176), J. J. L., Kinengyere, A. A., Bongomin, F., et al. (2026) · Tropical Medicine and Health · doi:10.1186/s41182-026-00938-2
Diallo, M. A., Tine, A., Sow, D., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01553-2
Putney, N., Sayyad-Hilario, J., Ukawuba, I., Grandesso, F., Singh, S., Safari, P. D., Pothin, E., Filippini, B., Djovouna, E., Diar, M. S. I., et al. (2026) · medRxiv · doi:10.64898/2026.03.23.26349112 · Cited by 1
Bioinformatics and biostatistical studies of the mosaic structures of microbial genomes
Tall, M. L. (2020) · theses.fr (ABES) · doi:10.70675/fb252c16z71b2z4b3dza1ccza62d6af2142f
Wazodan, A. M., Moustapha, L. M., Alkassoum, I., et al. (2026) · Pan African Medical Journal · doi:10.11604/pamj.2026.53.171.48880
“Ces résultats sont supérieurs à ceux d´une étude de cohorte menée au Mali en 2020 sur l´effet d'un cinquième passage, qui a montré une diminution de 19% [22].”
Boudoua, B., Guery, M.-A., Kanoute, M. B., et al. (2026) · medRxiv · doi:10.64898/2026.04.28.26351930
Cheng, N. I., Chu, C. E., Wu, X., Ndang, N. H., Amambua-Ngwa, B. N., Peprah, N. Y., Malm, K., Kotanmi, B., Dibbasey, M., Mohammed, N. N., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8908842/v1
Hicks, J. T., Munsey, A., Mousa, A., Cairns, M. E., Hill, A., Gowelo, S., Matambisso, G., Pujol, A., Mayor, A. G., Madanitsa, M., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101415 · Cited by 1
Yaro, J. B., Ouédraogo, A., Moreno, M., Koele, S. E., Sindie, S. S., Barry, A., Soremekun, S., Gmeiner, M., Lanke, K. H. W., Byrne, I., et al. (2026) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(26)00305-1 · Cited by 1
Simo, M. L. S., Efon-Ekangouo, A., Mayoh, F. C., Kengne, F. B., Nana-Djeunga, H. C., Kamgno, J., & Coppierters, Y. (2026) · International Health · doi:10.1093/inthealth/ihag083
Rouamba, T., KABORE, B., Paul, S., Ismael, B., Hien, F. S., Maïga, W. G., Millogo, K. S., Ipéné, M. C. B., Baowendsom, A. E. T., Compaore, E. W., et al. (2026) · Journal of Public Health and Epidemiology · doi:10.5897/jphe2026.1579
Nyongesa, F. N., Gathiaka, J. K., & Mwabu, G. (2026) · INTERNATIONAL JOURNAL OF MEDICAL EVALUATION AND PHYSICAL REPORT · doi:10.56201/ijmepr.v9.no7.2025.pg60.73
Cheng, N. I., Dibbasey, M., Chu, C. E., Ndang, N. H., Amambua-Ngwa, B. N., Baah, C. A., Adu, G. A., Owusu, D., Naabil, D. T., Etoketim, B. N., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-06166-7 · Cited by 1
Okell, L., Courlet, P., Venezia, F., Oeuvray, C., Demarta‐Gatsi, C., Spangenberg, T., & Okebe, J. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00434-26
“In some trials or implementation programs, certain countries have expanded SMC to older age groups, for example, 3 months to 10 years in Senegal (39), deployed chemoprevention in school-age children (40), or given MDA to the whole population of any age (usually excluding very young infants and pregnant women) (41).”
Nimpa, M. M., Dongmo, F. J., Wondji, C. S., et al. (2026) · AIMS Mathematics · doi:10.3934/math.20261359
Metadata
- Authors
- Cissé, B., Ba, E. H., Sokhna, C., NDiaye, J. L., Gomis, J. F., Dial, Y., Pitt, C., NDiaye, M., Cairns, M., Faye, E., NDiaye, M., Lo, A., Tine, R., Faye, S., Faye, B., Sy, O., Konate, L., Kouevijdin, E., Flach, C., Faye, O., Trape, J.-F., Sutherland, C., Fall, F. B., Thior, P. M., Faye, O. K., Greenwood, B., Gaye, O., & Milligan, P.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Institut de Recherche pour le Développement (SN)
- Cheikh Anta Diop University (SN)
- Corresponding author
- Milligan, Paul
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-22
- Volume
- 13
- Issue
- 11
- Pages
- e1002175
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5119693
- OpenAlex
- W2549904414
- Semantic Scholar
- e6a098bdd1abc4b8af46ccccb9f99306619a22fa
- Cited by
- 191
- References
- 10
- Citations by year
- 2026: 23 · 2025: 21 · 2024: 22 · 2023: 15 · 2022: 24 · 2021: 25 · 2020: 23 · 2019: 10 · 2018: 17 · 2017: 9 · 2016: 2
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation (40099)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- seasonal malaria chemoprevention, sulfadoxine-pyrimethamine, amodiaquine, malaria mortality, parasitemia, anemia, drug resistance, insecticide-treated nets, adverse drug reactions, community attitudes, Senegal
- MeSH terms
- Amodiaquine, Antimalarials, Child, Child, Preschool, Drug Combinations, Humans, Infant, Malaria, Pyrimethamine, Seasons, Senegal, Sulfadoxine, Chemoprevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.